BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 19896997)

  • 1. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
    J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
    Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles.
    Zhu Z; Xie C; Liu Q; Zhen X; Zheng X; Wu W; Li R; Ding Y; Jiang X; Liu B
    Biomaterials; 2011 Dec; 32(35):9525-35. PubMed ID: 21903260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
    Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
    Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth.
    Lee JY; Kim KS; Kang YM; Kim ES; Hwang SJ; Lee HB; Min BH; Kim JH; Kim MS
    Int J Pharm; 2010 Jun; 392(1-2):51-6. PubMed ID: 20298770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
    Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
    Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy.
    Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH
    J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
    J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.
    Yang R; Meng F; Ma S; Huang F; Liu H; Zhong Z
    Biomacromolecules; 2011 Aug; 12(8):3047-55. PubMed ID: 21726090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.
    Zhang L; He Y; Ma G; Song C; Sun H
    Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.
    Zhang Y; Tang L; Sun L; Bao J; Song C; Huang L; Liu K; Tian Y; Tian G; Li Z; Sun H; Mei L
    Acta Biomater; 2010 Jun; 6(6):2045-52. PubMed ID: 19969111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
    Shahin M; Lavasanifar A
    Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.